Aorta
/ diagnostic imaging
Calcinosis
Coronary Artery Disease
Fluorine Radioisotopes
Humans
Plaque, Atherosclerotic
Positron Emission Tomography Computed Tomography
/ methods
Positron-Emission Tomography
Predictive Value of Tests
Radiopharmaceuticals
Risk Factors
Sodium Fluoride
Tomography, X-Ray Computed
aortic dissection
aortic growth
intramural hematoma
major adverse aortic events
microcalcification
vascular injury
Journal
JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
24
08
2021
revised:
01
01
2022
accepted:
07
01
2022
entrez:
7
7
2022
pubmed:
8
7
2022
medline:
12
7
2022
Statut:
ppublish
Résumé
Acute aortic syndrome is associated with aortic medial degeneration. In a proof-of-concept study, this investigation aimed to establish whether Patients with aortic dissection or intramural hematomas and control subjects underwent Aortic In patients with acute aortic syndrome,
Sections du résumé
BACKGROUND
Acute aortic syndrome is associated with aortic medial degeneration.
OBJECTIVES
In a proof-of-concept study, this investigation aimed to establish whether
METHODS
Patients with aortic dissection or intramural hematomas and control subjects underwent
RESULTS
Aortic
CONCLUSIONS
In patients with acute aortic syndrome,
Identifiants
pubmed: 35798405
pii: S1936-878X(22)00046-8
doi: 10.1016/j.jcmg.2022.01.003
pii:
doi:
Substances chimiques
Fluorine Radioisotopes
0
Radiopharmaceuticals
0
Sodium Fluoride
8ZYQ1474W7
Banques de données
ClinicalTrials.gov
['NCT03647566']
Types de publication
Clinical Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1291-1304Subventions
Organisme : British Heart Foundation
ID : RG/16/10/32375
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/14/78/31020
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/09/002/26360
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/17/50/33061
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/19/15/34155
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0701127
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/ICRF/20/26002
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/18/31/33676
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Funding Support and Author Disclosure All funding support is from the United Kingdom. Mr Syed and Drs Fletcher, Dweck, Shah, and Tavares, Mr Kaczynki, and Dr Newby were supported by the British Heart Foundation (FS/18/31/33676, FS/19/15/34155, FS/11/014, FS/14/78/31020, CH/09/002, RG/16/10/32375, RE/18/5/34216). Dr Dweck has received the Sir Jules Thorn Award for Biomedical Research 2015 (15/JTA). Dr Newby has received a Wellcome Trust Senior Investigator Award (WT103782AIA). Dr van Beek has been supported by the Scottish Imaging Network—a Platform of Scientific Excellence (SINAPSE). Edinburgh Clinical Research Facility and Edinburgh Imaging Facility are supported by NHS Research Scotland. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.